Berkeley Capital Partners, LLC
Source: SEC Form 13F · as of Mar 2026Berkeley Capital Partners, LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $17.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$17.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 12,608 | $3.1M |
| PFEPFIZER INC | 95,642 | $2.7M |
| MRKMerck & Co., Inc. | 17,179 | $2.1M |
| PMPhilip Morris International Inc | 11,447 | $1.9M |
| ABBVAbbVie Inc. | 7,702 | $1.7M |
| NVSNovartis AG | 9,899 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 24,697 | $1.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,360 | $1.5M |
| LLYELI LILLY & Co | 1,376 | $1.3M |
| GILDGILEAD SCIENCES, INC. | 2,053 | $286K |
| NVONovo Nordisk A/S | 5,750 | $211K |
| MCKMcKesson Corporation | 240 | $208K |
| IBRXImmunityBio, Inc. | 10,000 | $77K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.